Garner, A. P., Gozgit, J. M., Anjum, R., Vodala, S., Schrock, A., Zhou, T., . . . Rivera, V. M. (2014). Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients. Clin Cancer Res.
استشهاد بنمط شيكاغوGarner, Andrew P., et al. "Ponatinib Inhibits Polyclonal Drug-resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients." Clin Cancer Res 2014.
MLA استشهادGarner, Andrew P., et al. "Ponatinib Inhibits Polyclonal Drug-resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients." Clin Cancer Res 2014.